Jason McCarthy
Stock Analyst at Maxim Group
(1.28)
# 2,645
Out of 4,433 analysts
128
Total ratings
30.09%
Success rate
-10.14%
Average return
Main Sectors:
78 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CNTX Context Therapeutics | Maintains: Buy | $4 → $10 | $2.00 | +400.00% | 2 | May 9, 2024 | |
| NRBO NeuroBo Pharmaceuticals | Initiates: Buy | $10 | $4.66 | +114.59% | 1 | May 8, 2024 | |
| TLPH Talphera | Initiates: Buy | $3 | $1.08 | +177.78% | 1 | May 6, 2024 | |
| LIPO Lipella Pharmaceuticals | Initiates: Buy | $2 | $0.75 | +166.31% | 1 | Apr 9, 2024 | |
| RZLT Rezolute | Initiates: Buy | $8 | $2.64 | +203.03% | 1 | Apr 9, 2024 | |
| ATAI Atai Life Sciences | Upgrades: Buy | $6 | $1.71 | +250.88% | 1 | Apr 3, 2024 | |
| MBRX Moleculin Biotech | Maintains: Buy | $45 → $20 | $5.08 | +293.70% | 1 | Mar 26, 2024 | |
| ATNM Actinium Pharmaceuticals | Maintains: Buy | $20 → $30 | $9.80 | +206.12% | 1 | Mar 19, 2024 | |
| BLTE Belite Bio | Initiates: Buy | $60 | $44.97 | +33.42% | 1 | Dec 14, 2023 | |
| ATXI Avenue Therapeutics | Initiates: Buy | $56 | $3.73 | +1,408.04% | 1 | Dec 11, 2023 | |
| RNXT RenovoRx | Downgrades: Hold | n/a | $1.37 | - | 2 | Nov 15, 2023 | |
| BNGO Bionano Genomics | Downgrades: Hold | n/a | $1.14 | - | 1 | Nov 13, 2023 | |
| CHRS Coherus BioSciences | Downgrades: Hold | n/a | $2.12 | - | 1 | Nov 8, 2023 | |
| BNOX Bionomics | Maintains: Buy | $7 → $10 | $0.90 | +1,008.16% | 2 | Sep 28, 2023 | |
| BCLI Brainstorm Cell Therapeutics | Downgrades: Hold | n/a | $0.52 | - | 3 | Sep 28, 2023 | |
| CYTH Cyclo Therapeutics | Upgrades: Buy | $4 | $1.40 | +185.71% | 2 | Sep 27, 2023 | |
| NLSP NLS Pharmaceutics AG | Downgrades: Hold | n/a | $0.16 | - | 4 | Sep 14, 2023 | |
| GANX Gain Therapeutics | Initiates: Buy | $10 | $2.63 | +280.23% | 1 | Sep 12, 2023 | |
| GNLX Genelux | Initiates: Buy | $40 | $3.65 | +995.89% | 1 | Sep 12, 2023 | |
| VTGN VistaGen Therapeutics | Maintains: Buy | $30 | $4.44 | +575.68% | 3 | Sep 5, 2023 | |
| MESO Mesoblast | Downgrades: Hold | n/a | $7.35 | - | 3 | Aug 7, 2023 | |
| GLMD Galmed Pharmaceuticals | Upgrades: Buy | $4 | $0.41 | +887.65% | 4 | Jul 24, 2023 | |
| KTRA Kintara Therapeutics | Upgrades: Buy | $14 | $0.14 | +9,690.21% | 2 | Jul 14, 2023 | |
| IMMP Immutep | Maintains: Buy | $8 → $10 | $2.96 | +237.84% | 2 | May 18, 2023 | |
| TCON TRACON Pharmaceuticals | Maintains: Buy | $160 → $60 | $1.43 | +4,095.80% | 1 | May 11, 2023 | |
| PSTV Plus Therapeutics | Maintains: Buy | $30 → $12 | $2.24 | +435.71% | 2 | May 3, 2023 | |
| RVPH Reviva Pharmaceuticals Holdings | Maintains: Buy | $10 → $18 | $1.67 | +977.84% | 3 | May 3, 2023 | |
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $325 → $400 | $445.21 | -10.15% | 3 | May 3, 2023 | |
| MNPR Monopar Therapeutics | Downgrades: Hold | n/a | $0.61 | - | 2 | Mar 29, 2023 | |
| PBLA Panbela Therapeutics | Upgrades: Buy | $900 | $0.44 | +204,398.98% | 3 | Mar 20, 2023 | |
| ZVRA Zevra Therapeutics | Initiates: Buy | $12 | $4.73 | +153.70% | 1 | Mar 17, 2023 | |
| APRE Aprea Therapeutics | Initiates: Buy | $16 | $5.27 | +203.61% | 1 | Mar 10, 2023 | |
| UNCY Unicycive Therapeutics | Maintains: Buy | $3 → $6 | $1.04 | +476.92% | 2 | Mar 9, 2023 | |
| SNPX Synaptogenix | Downgrades: Hold | n/a | $4.75 | - | 2 | Dec 19, 2022 | |
| ACHV Achieve Life Sciences | Maintains: Buy | $21 → $8 | $5.00 | +60.00% | 1 | Nov 16, 2022 | |
| ABVC ABVC BioPharma | Downgrades: Hold | n/a | $1.07 | - | 1 | Nov 16, 2022 | |
| INO Inovio Pharmaceuticals | Downgrades: Hold | n/a | $12.00 | - | 4 | Nov 9, 2022 | |
| GILD Gilead Sciences | Maintains: Buy | $84 → $92 | $67.72 | +35.85% | 3 | Oct 31, 2022 | |
| ONCY Oncolytics Biotech | Initiates: Buy | $3 | $1.11 | +170.27% | 1 | Oct 6, 2022 | |
| VNRX VolitionRx | Maintains: Buy | $8 → $5 | $0.77 | +549.35% | 1 | Aug 23, 2022 | |
| ADIL Adial Pharmaceuticals | Downgrades: Hold | n/a | $1.55 | - | 1 | Aug 17, 2022 | |
| ARDS Aridis Pharmaceuticals | Downgrades: Hold | n/a | $0.06 | - | 1 | Aug 16, 2022 | |
| KZIA Kazia Therapeutics | Downgrades: Hold | n/a | $0.28 | - | 1 | Aug 2, 2022 | |
| FEMY Femasys | Initiates: Buy | $5 | $1.27 | +293.70% | 1 | Jun 17, 2022 | |
| TTNP Titan Pharmaceuticals | Downgrades: Hold | n/a | $6.34 | - | 4 | May 26, 2022 | |
| GOVX GeoVax Labs | Reiterates: Buy | $90 | $1.70 | +5,194.12% | 2 | May 23, 2022 | |
| INVO INVO Bioscience | Initiates: Buy | $140 | $0.99 | +14,113.20% | 1 | Jan 19, 2022 | |
| KPRX Kiora Pharmaceuticals | Initiates: Buy | $100 | $0.57 | +17,443.86% | 1 | Jan 19, 2022 | |
| ACXP Acurx Pharmaceuticals | Initiates: Buy | n/a | $2.25 | - | 1 | Nov 29, 2021 | |
| CYBN Cybin | Downgrades: Hold | n/a | $0.35 | - | 1 | Nov 19, 2021 | |
| PTIX Protagenic Therapeutics | Initiates: Buy | n/a | $1.50 | - | 1 | Oct 29, 2021 | |
| INDP Indaptus Therapeutics | Upgrades: Buy | n/a | $2.31 | - | 1 | Oct 19, 2021 | |
| OMER Omeros | Downgrades: Hold | n/a | $3.45 | - | 4 | Oct 4, 2021 | |
| ATNF 180 Life Sciences | Initiates: Buy | $4,180 | $1.58 | +264,456.96% | 1 | Sep 15, 2021 | |
| CMPS COMPASS Pathways | Initiates: Buy | n/a | $7.84 | - | 1 | Jun 28, 2021 | |
| ENVB Enveric Biosciences | Initiates: Buy | n/a | $0.84 | - | 1 | Jun 28, 2021 | |
| MNMD Mind Medicine (MindMed) | Initiates: Buy | n/a | $8.22 | - | 1 | Jun 28, 2021 | |
| CLNN Clene | Initiates: Buy | n/a | $0.37 | - | 1 | May 20, 2021 | |
| CWBR CohBar | Initiates: Buy | n/a | $0.88 | - | 1 | Apr 23, 2021 | |
| FENC Fennec Pharmaceuticals | Initiates: Buy | n/a | $7.04 | - | 1 | Apr 19, 2021 | |
| CODX Co-Diagnostics | Downgrades: Hold | n/a | $1.09 | - | 2 | Mar 29, 2021 | |
| MNOV MediciNova | Initiates: Buy | n/a | $1.42 | - | 1 | Mar 10, 2021 | |
| SAVA Cassava Sciences | Maintains: Buy | n/a | $23.12 | - | 2 | Feb 16, 2021 | |
| ARTL Artelo Biosciences | Upgrades: Buy | n/a | $1.42 | - | 2 | Jan 7, 2021 | |
| GLPG Galapagos NV | Initiates: Buy | n/a | $29.63 | - | 1 | Nov 19, 2020 | |
| TFFP TFF Pharmaceuticals | Initiates: Buy | $300 | $2.16 | +13,788.89% | 1 | Jul 8, 2020 | |
| DMAC DiaMedica Therapeutics | Initiates: Buy | n/a | $3.17 | - | 1 | Jul 8, 2020 | |
| CLRB Cellectar Biosciences | Initiates: Buy | n/a | $3.30 | - | 1 | Jun 23, 2020 | |
| APTO Aptose Biosciences | Initiates: Buy | n/a | $1.19 | - | 1 | Feb 20, 2020 | |
| ATOS Atossa Therapeutics | Upgrades: Buy | n/a | $1.57 | - | 1 | Dec 18, 2019 | |
| MTNB Matinas BioPharma Holdings | Maintains: Buy | n/a | $0.17 | - | 3 | Nov 13, 2018 | |
| SCYX SCYNEXIS | Maintains: Buy | n/a | $2.77 | - | 1 | Oct 16, 2018 | |
| ADMA ADMA Biologics | Maintains: Buy | n/a | $9.21 | - | 2 | Jul 27, 2018 | |
| SLS SELLAS Life Sciences Group | Maintains: Buy | n/a | $1.46 | - | 2 | Jul 20, 2018 | |
| BYSI BeyondSpring | Maintains: Buy | n/a | $2.68 | - | 1 | Jun 22, 2018 | |
| VKTX Viking Therapeutics | Maintains: Buy | n/a | $67.00 | - | 1 | Jun 1, 2018 | |
| BLFS BioLife Solutions | Maintains: Buy | n/a | $21.96 | - | 2 | May 11, 2018 | |
| BLUE bluebird bio | Downgrades: Hold | n/a | $1.03 | - | 3 | Dec 13, 2017 |
Context Therapeutics
May 9, 2024
Maintains: Buy
Price Target: $4 → $10
Current: $2.00
Upside: +400.00%
NeuroBo Pharmaceuticals
May 8, 2024
Initiates: Buy
Price Target: $10
Current: $4.66
Upside: +114.59%
Talphera
May 6, 2024
Initiates: Buy
Price Target: $3
Current: $1.08
Upside: +177.78%
Lipella Pharmaceuticals
Apr 9, 2024
Initiates: Buy
Price Target: $2
Current: $0.75
Upside: +166.31%
Rezolute
Apr 9, 2024
Initiates: Buy
Price Target: $8
Current: $2.64
Upside: +203.03%
Atai Life Sciences
Apr 3, 2024
Upgrades: Buy
Price Target: $6
Current: $1.71
Upside: +250.88%
Moleculin Biotech
Mar 26, 2024
Maintains: Buy
Price Target: $45 → $20
Current: $5.08
Upside: +293.70%
Actinium Pharmaceuticals
Mar 19, 2024
Maintains: Buy
Price Target: $20 → $30
Current: $9.80
Upside: +206.12%
Belite Bio
Dec 14, 2023
Initiates: Buy
Price Target: $60
Current: $44.97
Upside: +33.42%
Avenue Therapeutics
Dec 11, 2023
Initiates: Buy
Price Target: $56
Current: $3.73
Upside: +1,408.04%
RenovoRx
Nov 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.37
Upside: -
Bionano Genomics
Nov 13, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.14
Upside: -
Coherus BioSciences
Nov 8, 2023
Downgrades: Hold
Price Target: n/a
Current: $2.12
Upside: -
Bionomics
Sep 28, 2023
Maintains: Buy
Price Target: $7 → $10
Current: $0.90
Upside: +1,008.16%
Brainstorm Cell Therapeutics
Sep 28, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.52
Upside: -
Cyclo Therapeutics
Sep 27, 2023
Upgrades: Buy
Price Target: $4
Current: $1.40
Upside: +185.71%
NLS Pharmaceutics AG
Sep 14, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.16
Upside: -
Gain Therapeutics
Sep 12, 2023
Initiates: Buy
Price Target: $10
Current: $2.63
Upside: +280.23%
Genelux
Sep 12, 2023
Initiates: Buy
Price Target: $40
Current: $3.65
Upside: +995.89%
VistaGen Therapeutics
Sep 5, 2023
Maintains: Buy
Price Target: $30
Current: $4.44
Upside: +575.68%
Mesoblast
Aug 7, 2023
Downgrades: Hold
Price Target: n/a
Current: $7.35
Upside: -
Galmed Pharmaceuticals
Jul 24, 2023
Upgrades: Buy
Price Target: $4
Current: $0.41
Upside: +887.65%
Kintara Therapeutics
Jul 14, 2023
Upgrades: Buy
Price Target: $14
Current: $0.14
Upside: +9,690.21%
Immutep
May 18, 2023
Maintains: Buy
Price Target: $8 → $10
Current: $2.96
Upside: +237.84%
TRACON Pharmaceuticals
May 11, 2023
Maintains: Buy
Price Target: $160 → $60
Current: $1.43
Upside: +4,095.80%
Plus Therapeutics
May 3, 2023
Maintains: Buy
Price Target: $30 → $12
Current: $2.24
Upside: +435.71%
Reviva Pharmaceuticals Holdings
May 3, 2023
Maintains: Buy
Price Target: $10 → $18
Current: $1.67
Upside: +977.84%
Vertex Pharmaceuticals
May 3, 2023
Maintains: Buy
Price Target: $325 → $400
Current: $445.21
Upside: -10.15%
Monopar Therapeutics
Mar 29, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.61
Upside: -
Panbela Therapeutics
Mar 20, 2023
Upgrades: Buy
Price Target: $900
Current: $0.44
Upside: +204,398.98%
Zevra Therapeutics
Mar 17, 2023
Initiates: Buy
Price Target: $12
Current: $4.73
Upside: +153.70%
Aprea Therapeutics
Mar 10, 2023
Initiates: Buy
Price Target: $16
Current: $5.27
Upside: +203.61%
Unicycive Therapeutics
Mar 9, 2023
Maintains: Buy
Price Target: $3 → $6
Current: $1.04
Upside: +476.92%
Synaptogenix
Dec 19, 2022
Downgrades: Hold
Price Target: n/a
Current: $4.75
Upside: -
Achieve Life Sciences
Nov 16, 2022
Maintains: Buy
Price Target: $21 → $8
Current: $5.00
Upside: +60.00%
ABVC BioPharma
Nov 16, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.07
Upside: -
Inovio Pharmaceuticals
Nov 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $12.00
Upside: -
Gilead Sciences
Oct 31, 2022
Maintains: Buy
Price Target: $84 → $92
Current: $67.72
Upside: +35.85%
Oncolytics Biotech
Oct 6, 2022
Initiates: Buy
Price Target: $3
Current: $1.11
Upside: +170.27%
VolitionRx
Aug 23, 2022
Maintains: Buy
Price Target: $8 → $5
Current: $0.77
Upside: +549.35%
Adial Pharmaceuticals
Aug 17, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.55
Upside: -
Aridis Pharmaceuticals
Aug 16, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.06
Upside: -
Kazia Therapeutics
Aug 2, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.28
Upside: -
Femasys
Jun 17, 2022
Initiates: Buy
Price Target: $5
Current: $1.27
Upside: +293.70%
Titan Pharmaceuticals
May 26, 2022
Downgrades: Hold
Price Target: n/a
Current: $6.34
Upside: -
GeoVax Labs
May 23, 2022
Reiterates: Buy
Price Target: $90
Current: $1.70
Upside: +5,194.12%
INVO Bioscience
Jan 19, 2022
Initiates: Buy
Price Target: $140
Current: $0.99
Upside: +14,113.20%
Kiora Pharmaceuticals
Jan 19, 2022
Initiates: Buy
Price Target: $100
Current: $0.57
Upside: +17,443.86%
Acurx Pharmaceuticals
Nov 29, 2021
Initiates: Buy
Price Target: n/a
Current: $2.25
Upside: -
Cybin
Nov 19, 2021
Downgrades: Hold
Price Target: n/a
Current: $0.35
Upside: -
Protagenic Therapeutics
Oct 29, 2021
Initiates: Buy
Price Target: n/a
Current: $1.50
Upside: -
Indaptus Therapeutics
Oct 19, 2021
Upgrades: Buy
Price Target: n/a
Current: $2.31
Upside: -
Omeros
Oct 4, 2021
Downgrades: Hold
Price Target: n/a
Current: $3.45
Upside: -
180 Life Sciences
Sep 15, 2021
Initiates: Buy
Price Target: $4,180
Current: $1.58
Upside: +264,456.96%
COMPASS Pathways
Jun 28, 2021
Initiates: Buy
Price Target: n/a
Current: $7.84
Upside: -
Enveric Biosciences
Jun 28, 2021
Initiates: Buy
Price Target: n/a
Current: $0.84
Upside: -
Mind Medicine (MindMed)
Jun 28, 2021
Initiates: Buy
Price Target: n/a
Current: $8.22
Upside: -
Clene
May 20, 2021
Initiates: Buy
Price Target: n/a
Current: $0.37
Upside: -
CohBar
Apr 23, 2021
Initiates: Buy
Price Target: n/a
Current: $0.88
Upside: -
Fennec Pharmaceuticals
Apr 19, 2021
Initiates: Buy
Price Target: n/a
Current: $7.04
Upside: -
Co-Diagnostics
Mar 29, 2021
Downgrades: Hold
Price Target: n/a
Current: $1.09
Upside: -
MediciNova
Mar 10, 2021
Initiates: Buy
Price Target: n/a
Current: $1.42
Upside: -
Cassava Sciences
Feb 16, 2021
Maintains: Buy
Price Target: n/a
Current: $23.12
Upside: -
Artelo Biosciences
Jan 7, 2021
Upgrades: Buy
Price Target: n/a
Current: $1.42
Upside: -
Galapagos NV
Nov 19, 2020
Initiates: Buy
Price Target: n/a
Current: $29.63
Upside: -
TFF Pharmaceuticals
Jul 8, 2020
Initiates: Buy
Price Target: $300
Current: $2.16
Upside: +13,788.89%
DiaMedica Therapeutics
Jul 8, 2020
Initiates: Buy
Price Target: n/a
Current: $3.17
Upside: -
Cellectar Biosciences
Jun 23, 2020
Initiates: Buy
Price Target: n/a
Current: $3.30
Upside: -
Aptose Biosciences
Feb 20, 2020
Initiates: Buy
Price Target: n/a
Current: $1.19
Upside: -
Atossa Therapeutics
Dec 18, 2019
Upgrades: Buy
Price Target: n/a
Current: $1.57
Upside: -
Matinas BioPharma Holdings
Nov 13, 2018
Maintains: Buy
Price Target: n/a
Current: $0.17
Upside: -
SCYNEXIS
Oct 16, 2018
Maintains: Buy
Price Target: n/a
Current: $2.77
Upside: -
ADMA Biologics
Jul 27, 2018
Maintains: Buy
Price Target: n/a
Current: $9.21
Upside: -
SELLAS Life Sciences Group
Jul 20, 2018
Maintains: Buy
Price Target: n/a
Current: $1.46
Upside: -
BeyondSpring
Jun 22, 2018
Maintains: Buy
Price Target: n/a
Current: $2.68
Upside: -
Viking Therapeutics
Jun 1, 2018
Maintains: Buy
Price Target: n/a
Current: $67.00
Upside: -
BioLife Solutions
May 11, 2018
Maintains: Buy
Price Target: n/a
Current: $21.96
Upside: -
bluebird bio
Dec 13, 2017
Downgrades: Hold
Price Target: n/a
Current: $1.03
Upside: -